{"transactions":[{"id":817782,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54022,"kind":"person","name":"Stockburger Aileen Ptucha","position":1,"cik":"0001806682","reported_name":"Stockburger Aileen Ptucha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:30:43.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":2.37,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-26-015149","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226015149/ownership.xml","form_type":"4"}},{"id":817783,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:30:41.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":2.37,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-26-015148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226015148/ownership.xml","form_type":"4"}},{"id":817781,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54021,"kind":"person","name":"Wenderow Tal Baruch","position":1,"cik":"0001822324","reported_name":"Wenderow Tal Baruch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:30:40.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":2.37,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-26-015147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226015147/ownership.xml","form_type":"4"}},{"id":817780,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54020,"kind":"person","name":"Wilson David James","position":1,"cik":"0002052349","reported_name":"Wilson David James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:30:38.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":2.37,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-26-015146","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226015146/ownership.xml","form_type":"4"}},{"id":817779,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":19954,"kind":"person","name":"Burell Scott R","position":1,"cik":"0001399318","reported_name":"Burell Scott R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:30:10.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":2.37,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-26-015151","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226015151/ownership.xml","form_type":"4"}},{"id":817778,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54019,"kind":"person","name":"Laxminarain Prattipati","position":1,"cik":"0001725204","reported_name":"Laxminarain Prattipati","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-03T20:30:07.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":2.37,"exercise_date":"2026-04-01","expiration_date":"2036-04-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-26-015150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226015150/ownership.xml","form_type":"4"}},{"id":891727,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:45:22.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":480000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the \"Plan\"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan."}],"balance_after":480000,"derivative":{"exercise_price":2.1,"expiration_date":"2036-02-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":480000},"source":{"system":"sec-edgar","filing":"0001493152-26-007612","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226007612/ownership.xml","form_type":"4"}},{"id":891726,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65530,"kind":"person","name":"Diaz-Cartelle Juan","position":1,"cik":"0002001881","reported_name":"Diaz-Cartelle Juan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:45:21.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the \"Plan\"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan."}],"balance_after":105000,"derivative":{"exercise_price":2.1,"expiration_date":"2036-02-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001493152-26-007613","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226007613/ownership.xml","form_type":"4"}},{"id":891725,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65529,"kind":"person","name":"Sharon Simon","position":1,"cik":"0001851272","reported_name":"Sharon Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager, CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:45:19.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the \"Plan\"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan."}],"balance_after":105000,"derivative":{"exercise_price":2.1,"expiration_date":"2036-02-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001493152-26-007610","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226007610/ownership.xml","form_type":"4"}},{"id":891705,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65528,"kind":"person","name":"Vaknin Rachel","position":1,"cik":"0001923217","reported_name":"Vaknin Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:45:18.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended (the \"Plan\"): (a) on August 18, 2026, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration or forfeiture pursuant to the terms of the Plan."}],"balance_after":105000,"derivative":{"exercise_price":2.1,"expiration_date":"2036-02-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001493152-26-007611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315226007611/ownership.xml","form_type":"4"}},{"id":1279381,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65528,"kind":"person","name":"Vaknin Rachel","position":1,"cik":"0001923217","reported_name":"Vaknin Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:17.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 4,375 options have been met and, accordingly, vested."}],"balance_after":4375,"derivative":{"exercise_price":1.25,"exercise_date":"2025-02-05","expiration_date":"2034-02-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":4375},"source":{"system":"sec-edgar","filing":"0001493152-25-005409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005409/ownership.xml","form_type":"4"}},{"id":1279380,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65528,"kind":"person","name":"Vaknin Rachel","position":1,"cik":"0001923217","reported_name":"Vaknin Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:17.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":48125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":48125,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":48125},"source":{"system":"sec-edgar","filing":"0001493152-25-005409","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005409/ownership.xml","form_type":"4"}},{"id":1279384,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:16.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 12,000 options have been met and, accordingly, vested."}],"balance_after":12000,"derivative":{"exercise_price":1.25,"exercise_date":"2025-02-05","expiration_date":"2034-02-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001493152-25-005407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005407/ownership.xml","form_type":"4"}},{"id":1279383,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:16.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":228000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":228000,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":228000},"source":{"system":"sec-edgar","filing":"0001493152-25-005407","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005407/ownership.xml","form_type":"4"}},{"id":1279379,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65529,"kind":"person","name":"Sharon Simon","position":1,"cik":"0001851272","reported_name":"Sharon Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager, CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:14.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 8,750 options have been met and, accordingly, vested."}],"balance_after":8750,"derivative":{"exercise_price":1.25,"exercise_date":"2025-02-05","expiration_date":"2034-02-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001493152-25-005408","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005408/ownership.xml","form_type":"4"}},{"id":1279378,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65529,"kind":"person","name":"Sharon Simon","position":1,"cik":"0001851272","reported_name":"Sharon Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager, CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:14.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":43750,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001493152-25-005408","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005408/ownership.xml","form_type":"4"}},{"id":1279377,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65530,"kind":"person","name":"Diaz-Cartelle Juan","position":1,"cik":"0002001881","reported_name":"Diaz-Cartelle Juan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:13.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Such options, granted on February 26, 2024, were performance-based options the vesting of which was subject to the satisfaction of milestones. On February 5, 2025, the Compensation Committee of the Board of Directors of the Issuer confirmed and determined that the milestones with respect to 10,500 options have been met and, accordingly, vested."}],"balance_after":10500,"derivative":{"exercise_price":1.25,"exercise_date":"2025-02-05","expiration_date":"2034-02-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001493152-25-005406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005406/ownership.xml","form_type":"4"}},{"id":1279376,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65530,"kind":"person","name":"Diaz-Cartelle Juan","position":1,"cik":"0002001881","reported_name":"Diaz-Cartelle Juan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T21:30:13.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 5, 2025, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":42000,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001493152-25-005406","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225005406/ownership.xml","form_type":"4"}},{"id":1291242,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T21:30:08.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":1.93,"exercise_date":"2025-12-17","expiration_date":"2035-01-28","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-25-004279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225004279/ownership.xml","form_type":"4"}},{"id":1291241,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":19954,"kind":"person","name":"Burell Scott R","position":1,"cik":"0001399318","reported_name":"Burell Scott R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T21:30:07.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":1.93,"exercise_date":"2025-12-17","expiration_date":"2035-01-28","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-25-004278","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225004278/ownership.xml","form_type":"4"}},{"id":1291240,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54021,"kind":"person","name":"Wenderow Tal Baruch","position":1,"cik":"0001822324","reported_name":"Wenderow Tal Baruch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T21:30:06.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":1.93,"exercise_date":"2025-12-17","expiration_date":"2035-01-28","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-25-004277","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225004277/ownership.xml","form_type":"4"}},{"id":1291239,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54020,"kind":"person","name":"Wilson David James","position":1,"cik":"0002052349","reported_name":"Wilson David James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T21:30:04.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":1.93,"exercise_date":"2025-12-17","expiration_date":"2035-01-28","underlying":"Common Stock, par value $0.01 per share","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001493152-25-004276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225004276/ownership.xml","form_type":"4"}},{"id":1291237,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54022,"kind":"person","name":"Stockburger Aileen Ptucha","position":1,"cik":"0001806682","reported_name":"Stockburger Aileen Ptucha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T21:30:04.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":1.93,"exercise_date":"2025-12-17","expiration_date":"2035-01-28","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-25-004280","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225004280/ownership.xml","form_type":"4"}},{"id":1291238,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54019,"kind":"person","name":"Laxminarain Prattipati","position":1,"cik":"0001725204","reported_name":"Laxminarain Prattipati","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-30T21:30:03.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":1.93,"exercise_date":"2025-12-17","expiration_date":"2035-01-28","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-25-004275","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315225004275/ownership.xml","form_type":"4"}},{"id":1620644,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65530,"kind":"person","name":"Diaz-Cartelle Juan","position":1,"cik":"0002001881","reported_name":"Diaz-Cartelle Juan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:19.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":17500,"derivative":{"exercise_price":1.2684,"expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001493152-24-007870","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007870/ownership.xml","form_type":"4"}},{"id":1620643,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65529,"kind":"person","name":"Sharon Simon","position":1,"cik":"0001851272","reported_name":"Sharon Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager, CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:14.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17500,"derivative":{"exercise_price":1.2684,"exercise_date":"2024-02-22","expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001493152-24-007872","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007872/ownership.xml","form_type":"4"}},{"id":1620642,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65529,"kind":"person","name":"Sharon Simon","position":1,"cik":"0001851272","reported_name":"Sharon Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager, CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:14.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":17500,"derivative":{"exercise_price":1.2684,"expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001493152-24-007872","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007872/ownership.xml","form_type":"4"}},{"id":1620641,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65528,"kind":"person","name":"Vaknin Rachel","position":1,"cik":"0001923217","reported_name":"Vaknin Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:12.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17500,"derivative":{"exercise_price":1.2684,"exercise_date":"2024-02-22","expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001493152-24-007873","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007873/ownership.xml","form_type":"4"}},{"id":1620640,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65528,"kind":"person","name":"Vaknin Rachel","position":1,"cik":"0001923217","reported_name":"Vaknin Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:12.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":17500,"derivative":{"exercise_price":1.2684,"expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001493152-24-007873","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007873/ownership.xml","form_type":"4"}},{"id":1620639,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:08.000Z","date":"2024-02-26","kind":"grant","planned":false,"acquired":true,"shares":79567,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79567,"derivative":{"exercise_price":1.25,"exercise_date":"2024-02-26","expiration_date":"2034-02-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":79567},"source":{"system":"sec-edgar","filing":"0001493152-24-007871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007871/ownership.xml","form_type":"4"}},{"id":1620638,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:08.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80000,"derivative":{"exercise_price":1.2684,"exercise_date":"2024-02-22","expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-24-007871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007871/ownership.xml","form_type":"4"}},{"id":1620637,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T23:41:08.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on August 22, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":80000,"derivative":{"exercise_price":1.2684,"expiration_date":"2034-02-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-24-007871","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315224007871/ownership.xml","form_type":"4"}},{"id":1749084,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":19954,"kind":"person","name":"Burell Scott R","position":1,"cik":"0001399318","reported_name":"Burell Scott R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T21:15:29.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":74218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":74218,"derivative":{"exercise_price":1.28,"expiration_date":"2033-11-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":74218},"source":{"system":"sec-edgar","filing":"0001493152-23-039530","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223039530/ownership.xml","form_type":"4"}},{"id":1749082,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54021,"kind":"person","name":"Wenderow Tal Baruch","position":1,"cik":"0001822324","reported_name":"Wenderow Tal Baruch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T21:15:27.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":74218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":74218,"derivative":{"exercise_price":1.28,"expiration_date":"2033-11-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":74218},"source":{"system":"sec-edgar","filing":"0001493152-23-039529","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223039529/ownership.xml","form_type":"4"}},{"id":1749083,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T21:15:24.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":74218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":74218,"derivative":{"exercise_price":1.28,"expiration_date":"2033-11-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":74218},"source":{"system":"sec-edgar","filing":"0001493152-23-039531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223039531/ownership.xml","form_type":"4"}},{"id":1749081,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54022,"kind":"person","name":"Stockburger Aileen Ptucha","position":1,"cik":"0001806682","reported_name":"Stockburger Aileen Ptucha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T21:15:21.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":74218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":74218,"derivative":{"exercise_price":1.28,"expiration_date":"2033-11-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":74218},"source":{"system":"sec-edgar","filing":"0001493152-23-039528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223039528/ownership.xml","form_type":"4"}},{"id":1749079,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T21:15:18.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":74218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":74218,"derivative":{"exercise_price":1.28,"expiration_date":"2033-11-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":74218},"source":{"system":"sec-edgar","filing":"0001493152-23-039527","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223039527/ownership.xml","form_type":"4"}},{"id":1749080,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54019,"kind":"person","name":"Laxminarain Prattipati","position":1,"cik":"0001725204","reported_name":"Laxminarain Prattipati","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T21:15:16.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":74218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":74218,"derivative":{"exercise_price":1.28,"expiration_date":"2033-11-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":74218},"source":{"system":"sec-edgar","filing":"0001493152-23-039526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223039526/ownership.xml","form_type":"4"}},{"id":1817057,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:30:57.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on February 1, 2024, the options shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":80000,"derivative":{"exercise_price":2.43,"expiration_date":"2033-08-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001493152-23-026630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223026630/ownership.xml","form_type":"4"}},{"id":1817056,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65529,"kind":"person","name":"Sharon Simon","position":1,"cik":"0001851272","reported_name":"Sharon Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager, CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:30:43.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on February 1, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":17500,"derivative":{"exercise_price":2.43,"expiration_date":"2033-08-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001493152-23-026631","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223026631/ownership.xml","form_type":"4"}},{"id":1817055,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":110904,"kind":"person","name":"Morag Eyal","position":1,"cik":"0001805787","reported_name":"Morag Eyal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:30:42.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on February 1, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":17500,"derivative":{"exercise_price":2.43,"expiration_date":"2033-08-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001493152-23-026629","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223026629/ownership.xml","form_type":"4"}},{"id":1817054,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65528,"kind":"person","name":"Vaknin Rachel","position":1,"cik":"0001923217","reported_name":"Vaknin Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:30:38.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on February 1, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":17500,"derivative":{"exercise_price":2.43,"expiration_date":"2033-08-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001493152-23-026628","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223026628/ownership.xml","form_type":"4"}},{"id":2051575,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":110904,"kind":"person","name":"Morag Eyal","position":1,"cik":"0001805787","reported_name":"Morag Eyal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T13:27:14.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on July 17, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":35000,"derivative":{"exercise_price":3.48,"expiration_date":"2033-01-17","underlying":"Common Stock, par value $0.01 per share","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-23-001824","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223001824/ownership.xml","form_type":"4"}},{"id":2051574,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65529,"kind":"person","name":"Sharon Simon","position":1,"cik":"0001851272","reported_name":"Sharon Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager, CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-19T13:25:19.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on July 17, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":35000,"derivative":{"exercise_price":3.48,"expiration_date":"2033-01-17","underlying":"Common Stock, par value $0.01 per share","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-23-001822","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223001822/ownership.xml","form_type":"4"}},{"id":2059367,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65528,"kind":"person","name":"Vaknin Rachel","position":1,"cik":"0001923217","reported_name":"Vaknin Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T11:15:10.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on June 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13000,"derivative":{"exercise_price":3.73,"expiration_date":"2032-12-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001493152-23-000884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223000884/ownership.xml","form_type":"4"}},{"id":2059375,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T11:03:25.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on June 21, 2023, the options shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":160000,"derivative":{"exercise_price":3.73,"expiration_date":"2032-12-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001493152-23-000874","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223000874/ownership.xml","form_type":"4"}},{"id":2152287,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54022,"kind":"person","name":"Stockburger Aileen Ptucha","position":1,"cik":"0001806682","reported_name":"Stockburger Aileen Ptucha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T20:34:40.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":16637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":16637,"derivative":{"exercise_price":5.71,"expiration_date":"2032-09-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":16637},"source":{"system":"sec-edgar","filing":"0001493152-22-026696","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222026696/ownership.xml","form_type":"4"}},{"id":2152286,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T10:41:25.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":16637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":16637,"derivative":{"exercise_price":5.71,"expiration_date":"2032-09-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":16637},"source":{"system":"sec-edgar","filing":"0001493152-22-026614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222026614/ownership.xml","form_type":"4"}},{"id":2152285,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T10:39:39.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":16637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":16637,"derivative":{"exercise_price":5.71,"expiration_date":"2032-09-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":16637},"source":{"system":"sec-edgar","filing":"0001493152-22-026613","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222026613/ownership.xml","form_type":"4"}},{"id":2152284,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54021,"kind":"person","name":"Wenderow Tal Baruch","position":1,"cik":"0001822324","reported_name":"Wenderow Tal Baruch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T10:37:45.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":16637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":16637,"derivative":{"exercise_price":5.71,"expiration_date":"2032-09-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":16637},"source":{"system":"sec-edgar","filing":"0001493152-22-026612","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222026612/ownership.xml","form_type":"4"}},{"id":2152283,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":19954,"kind":"person","name":"Burell Scott R","position":1,"cik":"0001399318","reported_name":"Burell Scott R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T10:36:20.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":16637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":16637,"derivative":{"exercise_price":5.71,"expiration_date":"2032-09-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":16637},"source":{"system":"sec-edgar","filing":"0001493152-22-026611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222026611/ownership.xml","form_type":"4"}},{"id":2152282,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54019,"kind":"person","name":"Laxminarain Prattipati","position":1,"cik":"0001725204","reported_name":"Laxminarain Prattipati","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T10:33:23.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":16637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":16637,"derivative":{"exercise_price":5.71,"expiration_date":"2032-09-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":16637},"source":{"system":"sec-edgar","filing":"0001493152-22-026610","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222026610/ownership.xml","form_type":"4"}},{"id":2204721,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65528,"kind":"person","name":"Vaknin Rachel","position":1,"cik":"0001923217","reported_name":"Vaknin Rachel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-20T20:30:17.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on January 18, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":10000,"derivative":{"exercise_price":4.7973,"expiration_date":"2032-07-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-22-019940","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222019940/ownership.xml","form_type":"4"}},{"id":2423192,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":110904,"kind":"person","name":"Morag Eyal","position":1,"cik":"0001805787","reported_name":"Morag Eyal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-28T21:30:51.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on July 26, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":25000,"derivative":{"exercise_price":6.48,"expiration_date":"2032-01-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-22-002553","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222002553/ownership.xml","form_type":"4"}},{"id":2423191,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":65529,"kind":"person","name":"Sharon Simon","position":1,"cik":"0001851272","reported_name":"Sharon Simon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Manager, CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-28T21:30:42.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on July 26, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":25000,"derivative":{"exercise_price":6.48,"expiration_date":"2032-01-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-22-002552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222002552/ownership.xml","form_type":"4"}},{"id":2423190,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-28T21:30:34.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan (the \"Plan\"): (a) on July 26, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":100000,"derivative":{"exercise_price":6.48,"expiration_date":"2032-01-26","underlying":"Common Stock, par value $0.01 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-22-002551","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222002551/ownership.xml","form_type":"4"}},{"id":2550252,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54021,"kind":"person","name":"Wenderow Tal Baruch","position":1,"cik":"0001822324","reported_name":"Wenderow Tal Baruch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T22:27:22.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":13571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 29, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13571,"derivative":{"exercise_price":7,"expiration_date":"2031-09-29","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13571},"source":{"system":"sec-edgar","filing":"0001493152-21-024680","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221024680/ownership.xml","form_type":"4"}},{"id":2550251,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54022,"kind":"person","name":"Stockburger Aileen Ptucha","position":1,"cik":"0001806682","reported_name":"Stockburger Aileen Ptucha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T22:24:58.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":13571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 29, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13571,"derivative":{"exercise_price":7,"expiration_date":"2031-09-29","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13571},"source":{"system":"sec-edgar","filing":"0001493152-21-024678","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221024678/ownership.xml","form_type":"4"}},{"id":2550250,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54019,"kind":"person","name":"Laxminarain Prattipati","position":1,"cik":"0001725204","reported_name":"Laxminarain Prattipati","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T22:22:41.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":13571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 29, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13571,"derivative":{"exercise_price":7,"expiration_date":"2031-09-29","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13571},"source":{"system":"sec-edgar","filing":"0001493152-21-024676","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221024676/ownership.xml","form_type":"4"}},{"id":2550212,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":19954,"kind":"person","name":"Burell Scott R","position":1,"cik":"0001399318","reported_name":"Burell Scott R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T22:20:06.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":13571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 29, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13571,"derivative":{"exercise_price":7,"expiration_date":"2031-09-29","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13571},"source":{"system":"sec-edgar","filing":"0001493152-21-024674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221024674/ownership.xml","form_type":"4"}},{"id":2550213,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T22:15:15.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":13571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 29, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13571,"derivative":{"exercise_price":7,"expiration_date":"2031-09-29","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13571},"source":{"system":"sec-edgar","filing":"0001493152-21-024672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221024672/ownership.xml","form_type":"4"}},{"id":2550211,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T22:12:05.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":13571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 29, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13571,"derivative":{"exercise_price":7,"expiration_date":"2031-09-29","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13571},"source":{"system":"sec-edgar","filing":"0001493152-21-024670","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221024670/ownership.xml","form_type":"4"}},{"id":2883346,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T22:15:52.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on February 1, 2022, the options shall vest and shall become exercisable with respect to 50% of the common stock; and (b) on a quarterly basis thereafter over the following year, the option shall equally vest and become exercisable with respect to the remaining 50% of the common stock."}],"balance_after":190000,"derivative":{"exercise_price":8.48,"expiration_date":"2031-02-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001493152-21-002536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221002536/ownership.xml","form_type":"4"}},{"id":2988788,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54019,"kind":"person","name":"Laxminarain Prattipati","position":1,"cik":"0001725204","reported_name":"Laxminarain Prattipati","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-09T22:15:13.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on May 5, 2021, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2771,"derivative":{"exercise_price":7.22,"expiration_date":"2030-11-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001493152-20-020846","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220020846/ownership.xml","form_type":"4"}},{"id":2988791,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":19954,"kind":"person","name":"Burell Scott R","position":1,"cik":"0001399318","reported_name":"Burell Scott R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-09T22:15:12.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on May 5, 2021, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2771,"derivative":{"exercise_price":7.22,"expiration_date":"2030-11-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001493152-20-020845","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220020845/ownership.xml","form_type":"4"}},{"id":2988787,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-09T22:15:10.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on May 5, 2021, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2771,"derivative":{"exercise_price":7.22,"expiration_date":"2030-11-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001493152-20-020844","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220020844/ownership.xml","form_type":"4"}},{"id":2988786,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-09T22:15:10.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on May 5, 2021, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2771,"derivative":{"exercise_price":7.22,"expiration_date":"2030-11-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001493152-20-020843","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220020843/ownership.xml","form_type":"4"}},{"id":3002449,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-21T21:25:28.000Z","date":"2020-10-12","kind":"sale","acquired":false,"shares":20000,"price":7.8449,"value":156898.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The original Form 4 filed on October 13, 2020 is amended by this Form 4 amendment to correctly reflect the transaction date in Table 1, Item 2. No other changes have been made to the original Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 12, 2020. Accordingly, Reporting Person beneficially owned 246,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":246909,"source":{"system":"sec-edgar","filing":"0001493152-20-019763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019763/ownership.xml","form_type":"4/A","original_submission_date":"2020-10-13"}},{"id":3002447,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-21T21:22:42.000Z","date":"2020-10-19","kind":"sale","acquired":false,"shares":4881,"price":7.9358,"value":38734.6398,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 4,881 shares of Issuer common stock on October 19, 2020. Accordingly, Reporting Person beneficially owned 242,028 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":242028,"source":{"system":"sec-edgar","filing":"0001493152-20-019762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019762/ownership.xml","form_type":"4"}},{"id":3008759,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-13T21:00:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":20000,"price":7.8449,"value":156898.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 12, 2020. Accordingly, Reporting Person beneficially owned 246,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":246909,"source":{"system":"sec-edgar","filing":"0001493152-20-019358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019358/ownership.xml","form_type":"4"}},{"id":3012051,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T20:58:17.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":5119,"price":7.7431,"value":39636.9289,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 5, 2020. Accordingly, Reporting Person beneficially owned 266,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":266909,"source":{"system":"sec-edgar","filing":"0001493152-20-019036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019036/ownership.xml","form_type":"4"}},{"id":3012050,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T20:58:17.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":14881,"price":7.7423,"value":115213.1663,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 5, 2020. Accordingly, Reporting Person beneficially owned 266,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":272028,"source":{"system":"sec-edgar","filing":"0001493152-20-019036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019036/ownership.xml","form_type":"4"}},{"id":3035916,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54021,"kind":"person","name":"Wenderow Tal Baruch","position":1,"cik":"0001822324","reported_name":"Wenderow Tal Baruch","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-09T20:45:24.000Z","date":"2020-08-14","kind":"grant","acquired":true,"shares":4902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan (the \"Plan\"): (a) on February 14, 2021, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":4902,"derivative":{"exercise_price":8.16,"expiration_date":"2030-08-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":4902},"source":{"system":"sec-edgar","filing":"0001493152-20-017485","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220017485/ownership.xml","form_type":"4"}},{"id":3052978,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:30:27.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":119,"price":11.9113,"value":1417.4447,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 15,119 shares of Issuer common stock on August 17, 2020. Accordingly, Reporting Person beneficially owned 286,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":286909,"source":{"system":"sec-edgar","filing":"0001493152-20-016316","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220016316/ownership.xml","form_type":"4"}},{"id":3052977,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:30:27.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":15000,"price":10.1784,"value":152676.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 15,119 shares of Issuer common stock on August 17, 2020. Accordingly, Reporting Person beneficially owned 286,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":287028,"source":{"system":"sec-edgar","filing":"0001493152-20-016316","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220016316/ownership.xml","form_type":"4"}},{"id":3082031,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":110904,"kind":"person","name":"Morag Eyal","position":1,"cik":"0001805787","reported_name":"Morag Eyal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-16T21:05:20.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan (the \"Plan\"): (a) on December 15, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan and with respect to certain business transactions."}],"balance_after":25000,"derivative":{"exercise_price":6.16,"expiration_date":"2030-07-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-20-013462","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220013462/ownership.xml","form_type":"4"}},{"id":3082032,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54022,"kind":"person","name":"Stockburger Aileen Ptucha","position":1,"cik":"0001806682","reported_name":"Stockburger Aileen Ptucha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-16T21:04:20.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":6493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan (the \"Plan\"): (a) on March 26, 2021, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock, subject to acceleration pursuant to the terms of the Plan."}],"balance_after":6493,"derivative":{"exercise_price":6.16,"expiration_date":"2030-07-14","underlying":"Common Stock, par value $0.01 per share","underlying_shares":6493},"source":{"system":"sec-edgar","filing":"0001493152-20-013461","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220013461/ownership.xml","form_type":"4"}},{"id":3244850,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-27T22:00:11.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":166666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":166666,"derivative":{"exercise_price":9.64,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock, par value $0.01 per share","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001493152-20-003083","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220003083/ownership.xml","form_type":"4"}},{"id":3331853,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":59526,"kind":"person","name":"Gadot Harel","position":1,"cik":"0001690103","reported_name":"Gadot Harel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman, President and CEO"}}],"security":"Common Stock, par value $0.01 per share","published_at":"2019-12-26T12:36:53.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":40000,"price":10,"value":400000.0,"ownership":{"direct":false,"nature":"By MEDX Ventures Group, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in April 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Does not include any options to purchase common stock owned by the reporting person."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Gadot is the Chief Executive Officer, Company Group Chairman and majority equity owner of MEDX Venture Group and thus may be deemed to share voting and investment power over the shares beneficially owned by this entity."}],"balance_after":136847,"source":{"system":"sec-edgar","filing":"0001493152-19-019697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219019697/ownership.xml","form_type":"4"}},{"id":3387440,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-28T13:32:10.000Z","date":"2019-01-14","kind":"sale","acquired":false,"shares":281773,"price":8.16,"value":2299267.68,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000004/primary_doc.xml","form_type":"5"}},{"id":3387439,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-28T13:32:10.000Z","date":"2019-01-14","kind":"purchase","acquired":true,"shares":1773,"price":6.43,"value":11400.39,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000004/primary_doc.xml","form_type":"5"}},{"id":3387438,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-28T13:32:10.000Z","date":"2019-01-09","kind":"sale","acquired":false,"shares":1280,"price":2.27,"value":2905.6,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000004/primary_doc.xml","form_type":"5"}},{"id":3387437,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-28T13:32:10.000Z","date":"2019-01-09","kind":"purchase","acquired":true,"shares":14280,"price":2.19,"value":31273.2,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000004/primary_doc.xml","form_type":"5"}},{"id":3387436,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-28T13:32:10.000Z","date":"2019-01-08","kind":"sale","acquired":false,"shares":2269,"price":2.7,"value":6126.3,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000004/primary_doc.xml","form_type":"5"}},{"id":3388916,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T23:21:02.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on April 23, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":3952,"derivative":{"exercise_price":5.06,"expiration_date":"2029-10-23","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3952},"source":{"system":"sec-edgar","filing":"0001493152-19-015942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219015942/ownership.xml","form_type":"4"}},{"id":3388915,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":40918,"kind":"person","name":"Madden Martin J.","position":1,"cik":"0001696864","reported_name":"Madden Martin J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T23:16:26.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on April 23, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":3952,"derivative":{"exercise_price":5.06,"expiration_date":"2029-10-23","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3952},"source":{"system":"sec-edgar","filing":"0001493152-19-015938","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219015938/ownership.xml","form_type":"4"}},{"id":3388914,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":19954,"kind":"person","name":"Burell Scott R","position":1,"cik":"0001399318","reported_name":"Burell Scott R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T23:14:00.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on April 23, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":3952,"derivative":{"exercise_price":5.06,"expiration_date":"2029-10-23","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3952},"source":{"system":"sec-edgar","filing":"0001493152-19-015936","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219015936/ownership.xml","form_type":"4"}},{"id":3388913,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54019,"kind":"person","name":"Laxminarain Prattipati","position":1,"cik":"0001725204","reported_name":"Laxminarain Prattipati","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T23:11:58.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on April 23, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":3952,"derivative":{"exercise_price":5.06,"expiration_date":"2029-10-23","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3952},"source":{"system":"sec-edgar","filing":"0001493152-19-015931","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219015931/ownership.xml","form_type":"4"}},{"id":3388912,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154264,"kind":"person","name":"Waizer Yoav Zvi","position":1,"cik":"0001689845","reported_name":"Waizer Yoav Zvi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T23:10:07.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on April 23, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":3952,"derivative":{"exercise_price":5.06,"expiration_date":"2029-10-23","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3952},"source":{"system":"sec-edgar","filing":"0001493152-19-015927","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219015927/ownership.xml","form_type":"4"}},{"id":3391415,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-18T14:15:35.000Z","date":"2019-01-14","kind":"sale","acquired":true,"shares":281773,"price":8.16,"value":2299267.68,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000002/primary_doc.xml","form_type":"5"}},{"id":3391414,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-18T14:15:35.000Z","date":"2019-01-09","kind":"sale","acquired":true,"shares":2269,"price":2.7,"value":6126.3,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000002/primary_doc.xml","form_type":"5"}},{"id":3391413,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-18T14:15:35.000Z","date":"2019-01-09","kind":"purchase","acquired":true,"shares":14280,"price":2.19,"value":31273.2,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000002/primary_doc.xml","form_type":"5"}},{"id":3391412,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-18T14:15:35.000Z","date":"2019-01-08","kind":"sale","acquired":true,"shares":2269,"price":2.7,"value":6126.3,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001791387-19-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000002/primary_doc.xml","form_type":"5"}},{"id":3391326,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-18T13:40:07.000Z","date":"2018-11-26","kind":"purchase","acquired":true,"shares":37986,"price":1.95,"value":74072.7,"ownership":{"direct":true},"balance_after":348971,"source":{"system":"sec-edgar","filing":"0001791387-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000001/primary_doc.xml","form_type":"5"}},{"id":3391325,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-18T13:40:07.000Z","date":"2018-11-21","kind":"sale","acquired":true,"shares":6309,"price":2.96,"value":18674.64,"ownership":{"direct":true},"balance_after":348971,"source":{"system":"sec-edgar","filing":"0001791387-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000001/primary_doc.xml","form_type":"5"}},{"id":3391324,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-18T13:40:07.000Z","date":"2018-11-21","kind":"purchase","acquired":true,"shares":24873,"price":2.21,"value":54969.33,"ownership":{"direct":true},"balance_after":348971,"source":{"system":"sec-edgar","filing":"0001791387-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000001/primary_doc.xml","form_type":"5"}},{"id":3391323,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":154229,"kind":"person","name":"Mona Joseph","position":1,"cik":"0001791387","reported_name":"Mona Joseph","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Microbot Medical Common Stock","published_at":"2019-10-18T13:40:07.000Z","date":"2018-11-19","kind":"purchase","acquired":true,"shares":2400,"price":2.99,"value":7176.0,"ownership":{"direct":true},"balance_after":348971,"source":{"system":"sec-edgar","filing":"0001791387-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1791387/000179138719000001/primary_doc.xml","form_type":"5"}},{"id":3689885,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":54019,"kind":"person","name":"Laxminarain Prattipati","position":1,"cik":"0001725204","reported_name":"Laxminarain Prattipati","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T22:50:27.000Z","date":"2019-01-21","kind":"grant","acquired":true,"shares":2326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on March 4, 2019, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2326,"derivative":{"exercise_price":8.6,"expiration_date":"2029-01-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2326},"source":{"system":"sec-edgar","filing":"0001493152-19-000868","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219000868/ownership.xml","form_type":"4"}},{"id":3689884,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":19954,"kind":"person","name":"Burell Scott R","position":1,"cik":"0001399318","reported_name":"Burell Scott R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T22:47:22.000Z","date":"2019-01-21","kind":"grant","acquired":true,"shares":2326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on March 4, 2019, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2326,"derivative":{"exercise_price":8.6,"expiration_date":"2029-01-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2326},"source":{"system":"sec-edgar","filing":"0001493152-19-000866","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219000866/ownership.xml","form_type":"4"}},{"id":3689883,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T22:44:48.000Z","date":"2019-01-21","kind":"grant","acquired":true,"shares":2326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on March 4, 2019, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2326,"derivative":{"exercise_price":8.6,"expiration_date":"2029-01-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2326},"source":{"system":"sec-edgar","filing":"0001493152-19-000864","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219000864/ownership.xml","form_type":"4"}}],"next_cursor":"2019-01-23T22:44:48.000000Z,3689883"}